European journal of clinical investigation
-
Eur. J. Clin. Invest. · Sep 2018
Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
Acute coronary syndrome (ACS) patients are at an increased risk of major adverse cardiovascular events (MACE). The objective of our study was to assess whether cardiac biomarker like soluble ST2 (sST2) can predict MACE among ACS patients with diabetes. ⋯ The current study indicates that elevated levels of sST2 might be a suitable biomarker to evaluate the risk of future adverse cardiovascular events in ACS patients with diabetes.